197 related articles for article (PubMed ID: 34938737)
1. Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment.
Xu W; Anwaier A; Ma C; Liu W; Tian X; Su J; Zhu W; Shi G; Wei S; Xu H; Qu Y; Ye D; Zhang H
Front Cell Dev Biol; 2021; 9():785410. PubMed ID: 34938737
[No Abstract] [Full Text] [Related]
2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
Front Immunol; 2021; 12():734646. PubMed ID: 34795663
[TBL] [Abstract][Full Text] [Related]
3. m
Xu W; Tian X; Liu W; Anwaier A; Su J; Zhu W; Wan F; Shi G; Wei G; Qu Y; Zhang H; Ye D
Front Oncol; 2021; 11():709579. PubMed ID: 34295828
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma.
Xu W; Ma C; Liu W; Anwaier A; Tian X; Shi G; Qu Y; Wei S; Zhang H; Ye D
Cancer Immunol Immunother; 2022 Aug; 71(8):1923-1935. PubMed ID: 35043231
[TBL] [Abstract][Full Text] [Related]
5. Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma.
Xu W; Zhu W; Tian X; Liu W; Wu Y; Anwaier A; Su J; Wei S; Qu Y; Zhang H; Ye D
Front Cell Dev Biol; 2021; 9():772436. PubMed ID: 34957104
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
7. Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients.
Xiong Y; Wang Z; Zhou Q; Zeng H; Zhang H; Liu Z; Huang Q; Wang J; Chang Y; Xia Y; Wang Y; Liu L; Zhu Y; Xu L; Dai B; Bai Q; Guo J; Xu J
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32217761
[TBL] [Abstract][Full Text] [Related]
8. Protein Arginine Methyltransferases Refine the Classification of Clear Cell Renal Cell Carcinoma with Distinct Prognosis and Tumor Microenvironment Characteristics.
Ye S; Tian X; Anwaier A; Wei S; Liu W; Su J; Zhu S; Dai B; Gu J; Qu Y; Xu W; Zhang H; Ye D
Int J Biol Sci; 2023; 19(14):4552-4570. PubMed ID: 37781030
[No Abstract] [Full Text] [Related]
9. Spatial heterogeneity of tumor microenvironment influences the prognosis of clear cell renal cell carcinoma.
Zhang D; Ni Y; Wang Y; Feng J; Zhuang N; Li J; Liu L; Shen W; Zheng J; Zheng W; Qian C; Shan J; Zhou Z
J Transl Med; 2023 Jul; 21(1):489. PubMed ID: 37474942
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.
Teng ZH; Li WC; Li ZC; Wang YX; Han ZW; Zhang YP
Front Oncol; 2022; 12():1094248. PubMed ID: 36620592
[TBL] [Abstract][Full Text] [Related]
11. Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma.
Giraldo NA; Becht E; Vano Y; Petitprez F; Lacroix L; Validire P; Sanchez-Salas R; Ingels A; Oudard S; Moatti A; Buttard B; Bourass S; Germain C; Cathelineau X; Fridman WH; Sautès-Fridman C
Clin Cancer Res; 2017 Aug; 23(15):4416-4428. PubMed ID: 28213366
[No Abstract] [Full Text] [Related]
12. An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Tekpli X; Lien T; Røssevold AH; Nebdal D; Borgen E; Ohnstad HO; Kyte JA; Vallon-Christersson J; Fongaard M; Due EU; Svartdal LG; Sveli MAT; Garred Ø; ; Frigessi A; Sahlberg KK; Sørlie T; Russnes HG; Naume B; Kristensen VN
Nat Commun; 2019 Dec; 10(1):5499. PubMed ID: 31796750
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and Predictive Value of Tumor-infiltrating Leukocytes and of Immune Checkpoint Molecules PD1 and PDL1 in Clear Cell Renal Cell Carcinoma.
Stenzel PJ; Schindeldecker M; Tagscherer KE; Foersch S; Herpel E; Hohenfellner M; Hatiboglu G; Alt J; Thomas C; Haferkamp A; Roth W; Macher-Goeppinger S
Transl Oncol; 2020 Feb; 13(2):336-345. PubMed ID: 31881506
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
16. A novel prognostic model based on immunogenomics for clear cell renal cell carcinoma.
Wu Z; Shen Y; Fan D; Liu J; Chen D; Wang K; Xu X
Int Immunopharmacol; 2021 Jan; 90():107119. PubMed ID: 33243605
[TBL] [Abstract][Full Text] [Related]
17. Multi-omics profiles refine L-dopa decarboxylase (DDC) as a reliable biomarker for prognosis and immune microenvironment of clear cell renal cell carcinoma.
Chang K; Su J; Li C; Anwaier A; Liu W; Xu W; Qu Y; Zhang H; Ye D
Front Oncol; 2022; 12():1079446. PubMed ID: 36544704
[TBL] [Abstract][Full Text] [Related]
18. Global Characterization of Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Zheng Y; Wen Y; Cao H; Gu Y; Yan L; Wang Y; Wang L; Zhang L; Shao F
Onco Targets Ther; 2021; 14():2085-2100. PubMed ID: 33790572
[TBL] [Abstract][Full Text] [Related]
19. Adipogenic Transdifferentiation and Regulatory Factors Promote the Progression and the Immunotherapy Response of Renal Cell Carcinoma: Insights From Integrative Analysis.
Wang S; Wei X; Ji C; Wang Y; Zhang X; Cong R; Song N
Front Oncol; 2022; 12():781932. PubMed ID: 35356208
[TBL] [Abstract][Full Text] [Related]
20. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma.
Li Q; Wei K; Zhang X; Lv Y; Li M; Zhou C; Su S; Hou D; Hou J
Aging (Albany NY); 2023 Sep; 15(17):8908-8929. PubMed ID: 37688768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
